NFKB1 and Duchenne muscular dystrophy: As largely described, inflammatory events that characterize DMD patients are activated by dysfunctions in calcium channels and by the over-expression of ROS and NF-κB-dependent signaling factors, considered one of the most feasible therapeutic targets to alleviate inflammatory responses.